Effects of ozone therapy on cyclophosphamide-induced urinary bladder toxicity in rats. 2013

Seda Tasdemir, and Cemal Tasdemir, and Nigar Vardi, and Burhan Ates, and Elif Taslidere, and Merve G Karaaslan, and Hilal I Sapmaz, and Mustafa Sagir, and Ahmet Kurt, and Canan A Baser
Department of Pharmacology, Medical Faculty, Inonu University, Malatya, Turkey. sedamd23@gmail.com

OBJECTIVE This study investigated the efficacy of ozone therapy (OT) in a rat model of cyclophosphamide-induced hemorrhagic cystitis (HC). METHODS Forty Wistar Albino male rats were divided into five groups: sham, OT, cyclophosphamide (CP), OT+CP and CP+OT. Hemorrhagic cystitis (HC) was induced by intraperitoneal (i.p) administration a single dose of 100 mg/kg CP. OT was performed once daily for three days. The CP+OT group received OT (0.2 mg/kg) i.p 24 h after CP administration. CP was injected to the OT+CP group the day after the third course of OT. All animals were killed four days after CP administration. Bladder injury and oxidative stress parameters were determined from tissue samples. RESULTS We found small, but non-statistically significant biochemical and histological changes in the animals treated with OT alone. CP administration induced cystitis, as manifested by a marked loss of urothelial cells, as well as hemorrhaging and edema in the bladder as determined by histopathological examination. It also caused a significant decrease in the endogenous antioxidant compound glutathione (GSH) and elevation of lipid peroxidation, and nitric oxide (NO) and myeloperoxidase (MPO) levels in the rats' urinary bladder tissue. OT was able to ameliorate these changes; however these effects were prominent in the CP+OT group when compared with the OT+CP group.: For example, the NO level in the CP+OT group was 68% of the OT+CP group (p < 0.05). CONCLUSIONS OT prevented CP-induced urothelial damage by diminishing bladder oxidative stress, inflammation and NO levels. OT may help to ameliorate bladder damage induced by CP in the clinical setting.

UI MeSH Term Description Entries
D008297 Male Males
D008315 Malondialdehyde The dialdehyde of malonic acid. Malonaldehyde,Propanedial,Malonylaldehyde,Malonyldialdehyde,Sodium Malondialdehyde,Malondialdehyde, Sodium
D009569 Nitric Oxide A free radical gas produced endogenously by a variety of mammalian cells, synthesized from ARGININE by NITRIC OXIDE SYNTHASE. Nitric oxide is one of the ENDOTHELIUM-DEPENDENT RELAXING FACTORS released by the vascular endothelium and mediates VASODILATION. It also inhibits platelet aggregation, induces disaggregation of aggregated platelets, and inhibits platelet adhesion to the vascular endothelium. Nitric oxide activates cytosolic GUANYLATE CYCLASE and thus elevates intracellular levels of CYCLIC GMP. Endogenous Nitrate Vasodilator,Mononitrogen Monoxide,Nitric Oxide, Endothelium-Derived,Nitrogen Monoxide,Endothelium-Derived Nitric Oxide,Monoxide, Mononitrogen,Monoxide, Nitrogen,Nitrate Vasodilator, Endogenous,Nitric Oxide, Endothelium Derived,Oxide, Nitric,Vasodilator, Endogenous Nitrate
D010126 Ozone The unstable triatomic form of oxygen, O3. It is a powerful oxidant that is produced for various chemical and industrial uses. Its production is also catalyzed in the ATMOSPHERE by ULTRAVIOLET RAY irradiation of oxygen or other ozone precursors such as VOLATILE ORGANIC COMPOUNDS and NITROGEN OXIDES. About 90% of the ozone in the atmosphere exists in the stratosphere (STRATOSPHERIC OZONE). Ground Level Ozone,Low Level Ozone,Tropospheric Ozone,Level Ozone, Ground,Level Ozone, Low,Ozone, Ground Level,Ozone, Low Level,Ozone, Tropospheric
D001743 Urinary Bladder A musculomembranous sac along the URINARY TRACT. URINE flows from the KIDNEYS into the bladder via the ureters (URETER), and is held there until URINATION. Bladder,Bladder Detrusor Muscle,Detrusor Urinae,Bladder Detrusor Muscles,Bladder, Urinary,Detrusor Muscle, Bladder,Detrusor Muscles, Bladder
D003520 Cyclophosphamide Precursor of an alkylating nitrogen mustard antineoplastic and immunosuppressive agent that must be activated in the LIVER to form the active aldophosphamide. It has been used in the treatment of LYMPHOMA and LEUKEMIA. Its side effect, ALOPECIA, has been used for defleecing sheep. Cyclophosphamide may also cause sterility, birth defects, mutations, and cancer. (+,-)-2-(bis(2-Chloroethyl)amino)tetrahydro-2H-1,3,2-oxazaphosphorine 2-Oxide Monohydrate,B-518,Cyclophosphamide Anhydrous,Cyclophosphamide Monohydrate,Cyclophosphamide, (R)-Isomer,Cyclophosphamide, (S)-Isomer,Cyclophosphane,Cytophosphan,Cytophosphane,Cytoxan,Endoxan,NSC-26271,Neosar,Procytox,Sendoxan,B 518,B518,NSC 26271,NSC26271
D005978 Glutathione A tripeptide with many roles in cells. It conjugates to drugs to make them more soluble for excretion, is a cofactor for some enzymes, is involved in protein disulfide bond rearrangement and reduces peroxides. Reduced Glutathione,gamma-L-Glu-L-Cys-Gly,gamma-L-Glutamyl-L-Cysteinylglycine,Glutathione, Reduced,gamma L Glu L Cys Gly,gamma L Glutamyl L Cysteinylglycine
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D017208 Rats, Wistar A strain of albino rat developed at the Wistar Institute that has spread widely at other institutions. This has markedly diluted the original strain. Wistar Rat,Rat, Wistar,Wistar Rats
D051381 Rats The common name for the genus Rattus. Rattus,Rats, Laboratory,Rats, Norway,Rattus norvegicus,Laboratory Rat,Laboratory Rats,Norway Rat,Norway Rats,Rat,Rat, Laboratory,Rat, Norway,norvegicus, Rattus

Related Publications

Seda Tasdemir, and Cemal Tasdemir, and Nigar Vardi, and Burhan Ates, and Elif Taslidere, and Merve G Karaaslan, and Hilal I Sapmaz, and Mustafa Sagir, and Ahmet Kurt, and Canan A Baser
March 2005, Clinical and experimental pharmacology & physiology,
Seda Tasdemir, and Cemal Tasdemir, and Nigar Vardi, and Burhan Ates, and Elif Taslidere, and Merve G Karaaslan, and Hilal I Sapmaz, and Mustafa Sagir, and Ahmet Kurt, and Canan A Baser
April 2010, Biological trace element research,
Seda Tasdemir, and Cemal Tasdemir, and Nigar Vardi, and Burhan Ates, and Elif Taslidere, and Merve G Karaaslan, and Hilal I Sapmaz, and Mustafa Sagir, and Ahmet Kurt, and Canan A Baser
December 1961, Cancer research,
Seda Tasdemir, and Cemal Tasdemir, and Nigar Vardi, and Burhan Ates, and Elif Taslidere, and Merve G Karaaslan, and Hilal I Sapmaz, and Mustafa Sagir, and Ahmet Kurt, and Canan A Baser
February 2015, Tissue & cell,
Seda Tasdemir, and Cemal Tasdemir, and Nigar Vardi, and Burhan Ates, and Elif Taslidere, and Merve G Karaaslan, and Hilal I Sapmaz, and Mustafa Sagir, and Ahmet Kurt, and Canan A Baser
August 1976, Cancer,
Seda Tasdemir, and Cemal Tasdemir, and Nigar Vardi, and Burhan Ates, and Elif Taslidere, and Merve G Karaaslan, and Hilal I Sapmaz, and Mustafa Sagir, and Ahmet Kurt, and Canan A Baser
April 2019, Neurourology and urodynamics,
Seda Tasdemir, and Cemal Tasdemir, and Nigar Vardi, and Burhan Ates, and Elif Taslidere, and Merve G Karaaslan, and Hilal I Sapmaz, and Mustafa Sagir, and Ahmet Kurt, and Canan A Baser
January 1993, Cancer biotherapy,
Seda Tasdemir, and Cemal Tasdemir, and Nigar Vardi, and Burhan Ates, and Elif Taslidere, and Merve G Karaaslan, and Hilal I Sapmaz, and Mustafa Sagir, and Ahmet Kurt, and Canan A Baser
November 1982, Cancer treatment reports,
Seda Tasdemir, and Cemal Tasdemir, and Nigar Vardi, and Burhan Ates, and Elif Taslidere, and Merve G Karaaslan, and Hilal I Sapmaz, and Mustafa Sagir, and Ahmet Kurt, and Canan A Baser
March 2012, International neurourology journal,
Seda Tasdemir, and Cemal Tasdemir, and Nigar Vardi, and Burhan Ates, and Elif Taslidere, and Merve G Karaaslan, and Hilal I Sapmaz, and Mustafa Sagir, and Ahmet Kurt, and Canan A Baser
May 1976, Archives of internal medicine,
Copied contents to your clipboard!